| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Depakine | 300 ml | 12.43 | 29.70 | 10 % | | Sirup: Natrii Valproas 300mg / 5ml | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G |  |
| | | IP | CI | | Depakine | 60 ml | 12.43 | 29.95 | 10 % | | Solution (oral): Natrii Valproas 300 mg/ml | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | Depakine Chrono 500 | 60 Tablet(s) | 11.05 | 28.35 | 10 % | | comprimés à libération prolongée: Acidum Valproicum 145 mg et Natrii Valproas 333 mg Corresp. Natrii Valproas 500 mg (Corresp. Acidum Valproicum 433.94 Mg) | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | Depakine Chrono 300 - T | 100 Tablet(s) | 10.26 | 27.50 | 10 % | | comprimés à libération prolongée: Acidum Valproicum 87 mg et Natrii Valproas 199.8 mg Corresp. Natrii Valproas 300 mg (Corresp. Acidum Valproicum 260.36 Mg) | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | Orfiril | 250 ml | 8.80 | 26.00 | 10 % | | Sirup: Natrii Valproas 300mg / 5ml | Desitin Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | | Valproat chrono Desitin 300 mg ‐ I | 100 Tablet(s) | 8.71 | 25.90 | 10 % | | Delayed release tablets: 2 Active Agents | Desitin Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | | Valproat chrono Desitin 500 mg ‐ I | 60 Tablet(s) | 9.39 | 26.65 | 10 % | | Delayed release tablets: 2 Active Agents | Desitin Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | | Valproat Sandoz 300 mg | 100 Tablet(s) | 8.72 | 25.90 | 10 % | | Delayed release tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Valproat Sandoz 500 mg | 60 Tablet(s) | 9.39 | 26.65 | 10 % | | Delayed release tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Valproate Chrono Sanofi 500 mg | 60 | 9.39 | 26.65 | 10 % | | Divitabs: Acidum Valproicum 145 mg et Natrii Valproas 333 mg Corresp. Natrii Valproas 500 mg (Corresp. Acidum Valproicum 433.94 Mg) | Sanofi-Aventis
(Suisse) SA | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Valproate Chrono Sanofi 300 mg | 100 | 8.87 | 26.05 | 10 % | | Divitabs: Acidum Valproicum 87 mg et Natrii Valproas 199.8 mg Corresp. Natrii Valproas 300 mg (Corresp. Acidum Valproicum 260.36 Mg) | Sanofi-Aventis
(Suisse) SA | B / SL / SG | FB | | G | |
| | | IP | CI | | Convulex | 300 ml | 8.80 | 26.00 | 10 % | | Sirup: Natrii Valproas 50 mg/ml | axapharm ag | B / SL | FB | | G | |
| | | IP | CI | | Orfiril long 150 mg ‐ I | 100 Capsule(s) | 8.10 | 25.25 | 10 % | | Delayed release capsules: Natrii Valproas 150 mg | Desitin Pharma GmbH | ● B / SL | FB | | G | |
| | | IP | CI | | Orfiril long 300 mg ‐ I | 100 Capsule(s) | 13.28 | 30.85 | 10 % | | Delayed release capsules: Natrii Valproas 300 mg | Desitin Pharma GmbH | B / SL | FB | | G | |
| | | IP | CI | | Convulex 150 | 100 Capsule(s) | 7.23 | 17.10 | 10 % | | Capsules: Acidum Valproicum 150 mg | axapharm ag | B / SL | FB | | G | |
| | | IP | CI | | Convulex 300 | 100 Capsule(s) | 12.42 | 29.90 | 10 % | | Capsules: Acidum Valproicum 300 mg | axapharm ag | B / SL | FB | | G | |
| | | IP | CI | | Convulex 500 | 60 Capsule(s) | 10.57 | 27.90 | 10 % | | Capsules: Acidum Valproicum 500 mg | axapharm ag | B / SL | FB | | G | |
| | | IP | CI | | Orfiril long 500 mg ‐ I | 100 piece(s) | 19.48 | 37.60 | 10 % | | Minipacks mit Retard-Mini-Filmtabletten: Natrii Valproas 500 mg | Desitin Pharma GmbH | B / SL | FB | | G | |
| | | IP | CI | | Orfiril long 1000 mg ‐ I | 100 piece(s) | 36.59 | 56.20 | 10 % | | Minipacks mit Retard-Mini-Filmtabletten: Natrii Valproas 1000 mg | Desitin Pharma GmbH | B / SL | FB | | G | |
| | | IP | | | Orfiril 300mg/3mL ‐ I | 5 ampoule(s) | 49.28 | PR | k.A. | | Injection solution: Natrii Valproas 300mg / 3ml | Desitin Pharma GmbH | B | FB | | G | |
| | | IP | | | Depakine | ampoule(s) | PR | 49.50 | 10 % | | poudre et solvant pour solution injectable/pour perfusion: Natrii Valproas 400 mg | Sanofi-Aventis
(Suisse) SA | B | FB | | G | |
| | | | | | Depakote 250 mg | 30 Tablet(s) | PR | PR | k.A. | | Tablets: 2 Active Agents | Sanofi-Synthélabo
(Suisse) SA | B | FB | | G | |
| | | | | | Depakote 500 mg | 60 Tablet(s) | PR | PR | k.A. | | Tablets: 2 Active Agents | Sanofi-Synthélabo
(Suisse) SA | B | FB | | G | |
|
| L | | IP | CI | | Sabril | 100 Sachet(s) | 50.61 | 71.45 | 10 % | | Soluble Powder: Vigabatrinum 500 mg | Sanofi-Aventis
(Suisse) SA | A / SL | FB | | G | |
| L | | IP | CI | | Sabril | 100 Tablet(s) | 50.61 | 71.45 | 10 % | | Coated tablets: Vigabatrinum 500 mg | Sanofi-Aventis
(Suisse) SA | A / SL | FB | | G | |
